New drugs and new treatments.
D000287:Administration, Topical; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D003620:Dantrolene / Q000627:therapeutic use; D004338:Drug Combinations; D004358:Drug Therapy; D004335:Drug and Narcotic Control; D005938:Glucocorticoids; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D008972:Molindone / Q000627:therapeutic use; D010120:Oxytocics / Q000627:therapeutic use; D011282:Pregnenediones / Q000627:therapeutic use; D011460:Prostaglandins F / Q000627:therapeutic use; D011807:Quinolizines / Q000627:therapeutic use; D013258:Steroids, Chlorinated / Q000627:therapeutic use; D013259:Steroids, Fluorinated / Q000627:therapeutic use; D013726:Terbutaline / Q000627:therapeutic use; D014325:Tromethamine / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D004338:Drug Combinations; D005938:Glucocorticoids; D010120:Oxytocics; D011282:Pregnenediones; D011460:Prostaglandins F; D011807:Quinolizines; D013258:Steroids, Chlorinated; D013259:Steroids, Fluorinated; D014325:Tromethamine; D003620:Dantrolene; D013726:Terbutaline; D008972:Molindone; D007052:Ibuprofen